Activated endothelium

Activated endothelium refers to a phenotypic transformation of the vascular lining from a quiescent, anti-thrombotic state to a pro-inflammatory and pro-coagulant state. This activation is typically triggered by stimuli such as pro-inflammatory cytokines (TNF-alpha, IL-1beta), bacterial lipopolysaccharides, or mechanical shear stress (Pober et al., 2007, *Physiological Reviews*). Once activated, endothelial cells increase the expression of cell adhesion molecules like E-selectin, VCAM-1, and ICAM-1, which serve as anchors for leukocyte rolling, adhesion, and subsequent transmigration into underlying tissues (Hunt & Jurd, 1998, *Cardiovascular Research*). This state is a critical driver of chronic inflammatory diseases, including atherosclerosis, and is a hallmark of acute conditions like sepsis and cytokine storm (Gimbrone & Garcia-Cardena, 2016, *Circulation Research*). While it is a major focus of drug development, 'activated endothelium' is considered a physiological state or biological process rather than a single molecular target. Therapeutic strategies typically involve targeting specific molecules upregulated during this state or inhibiting the intracellular signaling cascades, such as the NF-kappaB pathway, that mediate the transition (Pober, 2002, *Journal of Clinical Investigation*).

Other names

Inflamed endotheliumEndothelial activationVascular endothelial activationPro-inflammatory endothelium

Inhibition of endothelial cell adhesion molecule expression (e.g., E-selectin, VCAM-1), blockade of leukocyte-endothelial interactions, or suppression of pro-inflammatory signaling pathways like NF-kappaB.